Table 2

Patient characteristics in various heart failure subcategorisations

HFpEFHFrEFHF-VHDHF-PHHF-RVSDχ²P value
n2022175924028958
Age (years)81±878±1081±978±1079±9<0.01
NT-proBNP1780±31113603±13 4502698±36282104±25882309±5051<0.01
Sex (male)684 (34%)1057 (60%)93 (39%)128 (44%)37 (64%)274<0.01
IHD552 (27%)881 (50%)54 (23%)66 (23%)12 (21%)265<0.01
VHD354 (18%)398 (23%)220 (92%)53 (18%)17 (29%)660<0.01
MI179 (9%)473 (27%)21 (9%)22 (8%)6 (10%)257<0.01
Obesity100 (5%)64 (4%)11 (5%)12 (4%)2 (3%)40.39
Hypertension1469 (73%)1022 (58%)141 (59%)192 (66%)32 (55%)96<0.01
Diabetes mellitus493 (24%)381 (22%)43 (18%)54 (19%)11 (19%)110.03
Hypercholesterolaemia473 (23%)357 (20%)28 (12%)41 (14%)7 (12%)31<0.01
COPD347 (17%)309 (18%)37 (15%)98 (34%)15 (26%)53<0.01
Dementia35 (2%)33 (2%)3 (1%)8 (3%)0 (0%)30.54
Smoker654 (32%)519 (30%)63 (26%)108 (37%)14 (24%)130.01
CVA277 (14%)255 (14%)29 (12%)30 (10%)7 (12%)40.36
  • COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; IHD, ischaemic heart disease; MI, myocardial infarction; NT-proBNP, N-terminal pro-brain-type natriuretic peptide; PH, pulmonary hypertension; RVSD, right ventricular systolic dysfunction; VHD, valvular heart disease.